Learn more

ONCOTHERAPY SCIENCE INC

Overview
  • Total Patents
    1,519
  • GoodIP Patent Rank
    6,675
  • Filing trend
    ⇩ 48.0%
About

ONCOTHERAPY SCIENCE INC has a total of 1,519 patent applications. It decreased the IP activity by 48.0%. Its first patent ever was published in 2001. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and China. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are INT INST CANCER IMMUNOLOGY INC, ONCOTHERAPY SCIENCE LTD and INST NAT SANTE RECH MED.

Patent filings per year

Chart showing ONCOTHERAPY SCIENCE INCs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Nakamura Yusuke 803
#2 Tsunoda Takuya 698
#3 Watanabe Tomohisa 321
#4 Ohsawa Ryuji 312
#5 Yoshimura Sachiko 310
#6 Osawa Ryuji 262
#7 Nakatsuru Shuichi 253
#8 Daigo Yataro 162
#9 Nishimura Yasuharu 122
#10 Katagiri Toyomasa 103

Latest patents

Publication Filing date Title
WO2021060343A1 T-cell receptor expressed by human t-cells that recognize peptide derived from urlc10 or peptide derived from depdc1
TW202023581A Cdca1-derived peptide and vaccine containing same
AU2018346765A1 Screening of T lymphocytes for cancer-specific antigens
TW201943715A Bicyclic compound and use thereof for inhibiting histone methyltransferase
WO2018165112A1 Bicyclic compound and use thereof for inhibiting histone methyltransferase
TW201831503A Mphosph1 epitope peptides for th1 cells and vaccines containing the same
TW201831502A Depdc1 epitope peptides for th1 cells and vaccines containing the same
TW201827465A Monoclonal antibody against fzd10 and use thereof
BR112019003408A2 monoclonal antibody against melk and its use
AU2016335731A1 FOXM1-derived peptide, and vaccine including same
BR112018006894A2 The vaccine containing MPHOSPH1 origin peptide and it
KR20180082432A Bicyclic compound and its use for inhibiting SUV39H2
SG10201913592QA Depdc1-derived peptide and vaccine containing same
TW201636358A GPC3 epitope peptides for TH1 cells and vaccines containing the same
EP3178837A1 Urlc10-derived peptide and vaccine containing same
CA2956127A1 Koc1-derived peptide and vaccine including same
KR20170040315A Cdca1-derived peptide and vaccine containing same
AU2015200800A1 Peptide Vaccines for Cancers Expressing Tumor-Associated Antigens
TW201829450A Imp-3 epitope peptides for th1 cells and vaccines containing the same
WO2014141652A1 Smyd3 peptides and vaccines containing the same